-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on NOV, Raises Price Target to $15

Benzinga·12/17/2025 17:52:37
Listen to the news
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $13 to $15.